← Back to Patent Explorer
US4266030A Expired / Lapsed US ⏱️ 0.0 years remaining

Macroporous polymeric carrier for covalently binding proteins, its preparation and its use for fixing active proteins

Assignee: BASF SE
•
Filing: 1980-05-05
•
Granted: 1981-05-05
•
Expires: 2000-05-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A macroporous crosslinked styrene resin, used as a carrier for covalently binding proteins, which resin contains isocyanate, thioisocyanate or aldehyde groups as protein-binding groups and may or may not contain sulfonic acid groups--which may also be in the form of the sodium salt or of sulfonic acid amide groups--as hydrophilic groups. The carrier according to the invention is prepared from a sulfochlorinated macroporous crosslinked styrene resin by reacting the sulfonic acid chloride groups with an α,ω-diamino compound, with hydrazine or with an α, ω-diamino-diether, converting any sulfonic acid chloride groups which may still be present to free sulfonic acid groups, their sodium salt or a sulfonamide group, and then reacting the terminal amino groups with phosgene, thiophosgene or a diisocyanate in order to produce the binding groups, which in turn fix a biologically active protein by covalent bonds.

Inventors

  • 👤 Chung-Ji Tschang
  • 👤 Heinrich Klefenz
  • 👤 Axel Sanner

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 12:26
CPC Classifications
C; C08; C08F; C08F8/00; C12; C12N; C12N11/00; C12N11/02; C12N11/08; C12N11/082

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 220 words
A macroporous crosslinked styrene resin, used as a carrier in which a biologically active protein is covalently bound via isocyanate, thiocyanate or aldehyde groups, wherein the sulfonic acid chloride groups of a sulfochlorinated macroporous crosslinked styrene resin, containing 1-4.5 milliequivalents/g of sulfonic acid chloride groups and consisting of 50-97% by weight of styrene and 3-50% by weight of divinylbenzene, with or without 1-25% by weight of ethylvinylbenzene and with or without 1-10% by weight, based on the total weight, of a further comonomer are reacted with an α,ω-diamino compound of the formula H.sub.2 N--(CH.sub.2).sub.n --NH.sub.2 where n is a number from 2 to 12, with hydrazine or with an α,ω-diamino-diether of the formula H.sub.2 N--(CH.sub.2).sub.3 --O--X--O--(CH.sub.2).sub.3 --NH.sub.2 where X is --(CH 2 ) n --, n being a number from 2 to 6, or where X is a 2,2-dimethyl-1,3-propylene or 3-methyl-1,5-pentylene radical, and any sulfonic acid chloride groups still remaining are hydrolyzed to the free sulfonic acid or saponified to its sodium salt or reacted with a primary or secondary amine to give sulfonamide groups, after which the terminal amino groups from the first process step are reacted with phosgene, thiophosgene, an aliphatic, aromatic or cycloaliphatic diisocyanate or an aliphatic dialdehyde of the formula OCH--(CH.sub.2).sub.n --CHO where n is a number from 1 to 8, to prepare the binding groups.
Claim 2
Dependent Claim 220 words
A macroporous crosslinked styrene resin, used as a carrier in which a biologically active protein is covalently bound via isocyanate, thiocyanate or aldehyde groups, wherein the sulfonic acid chloride groups of a sulfochlorinated macroporous crosslinked styrene resin, containing 1-4.5 milliequivalents/g of sulfonic acid chloride groups and consisting of 50-97% by weight of styrene and 3-50% by weight of divinylbenzene, with or without 1-25% by weight of ethylvinylbenzene and with or without 1-10% by weight, based on the total weight, of a further comonomer are reacted with an α,ω-diamino compound of the formula H.sub.2 N--(CH.sub.2).sub.n --NH.sub.2 where n is a number from 2 to 12, with hydrazine or with an α,ω-diamino-diether of the formula H.sub.2 N--(CH.sub.2).sub.3 --O--X--O--(CH.sub.2).sub.3 --NH.sub.2 where X is --(CH 2 ) n --, n being a number from 2 to 6, or where X is a 2,2-dimethyl-1,3-propylene or 3-methyl-1,5-pentylene radical, and any sulfonic acid chloride groups still remaining are hydrolyzed to the free sulfonic acid or saponified to its sodium salt or reacted with a primary or secondary amine to give sulfonamide groups, after which the terminal amino groups from the first process step are reacted with phosgene, thiophosgene, an aliphatic, aromatic or cycloaliphatic diisocyanate or an aliphatic dialdehyde of the formula OCH--(CH.sub.2).sub.n --CHO where n is a number from 1 to 8, to prepare the binding groups.
Claim 3
Dependent Claim 38 words
A process for fixing proteins wherein a carrier as set forth in claim 1 is stirred with the protein to be bound, in an aqueous solution, at from 0° to 50° C. for from 1/2 to 24 hours.
Claim 4
Dependent Claim 13 words
A process as set forth in claim 2 for fixing β-fructosidase or aminoacid-acylase.

References Cited (Backward Citations)

US3326866A Cited
US3458976A Cited
GB1257263A Cited
DE2621974A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-05-04 1984-11-03 1985-05-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-05-04 1988-11-03 1989-05-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-05-04 1992-11-03 1993-05-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag